Vivos Inc (RDGL)

[Mindsplit]

Post-treatment imaging using IsoPet successfully addressed questions previously raised by the Food and Drugs administration review panel.


“The successful treatment of the cat and dog subjects thus far increases the likelihood of IsoPet® becoming a practical solution in the treatment of animal cancer. Additionally, the data obtained at the University of Missouri will support the pre-clinical investigations required by the FDA to provide evidence that Radiogel™ can be safe and effective for treating various human cancer,” said CEO Mike Korenko.

Following the successful trials, the University of Missouri has started advertising the availability of IsoPet treatment, for dogs and other patients.